Investors who bought or otherwise acquired Amgen Inc. (AMGN) common stock between July 29, 2020 and April 27, 2022 may qualify to claim a pro rata share of the $74 million Amgen securities class action settlement. Claims are due February 9, 2027, and trade records are required.
Free settlement alerts
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
No. The $74 million settlement resolves shareholders' claims about how and when Amgen disclosed the tax dispute. The underlying dispute with the IRS over tax years 2010 through 2015 is a separate proceeding in the U.S. Tax Court and is not affected by the class settlement.
No. The $95 million Amgen securities settlement approved in 2016 came from an older case in the Central District of California. The $74 million settlement is in a different case, In re Amgen Inc. Securities Litigation, No. 1:23-cv-02138, in the Southern District of New York, with a 2020–2022 class period.
No. Amgen has said it believes the claims lack merit, and the settlement includes no admission of liability or wrongdoing.
Verita Global is the claims administrator. Claims, the notice and the plan of allocation are on the official Amgen Securities Settlement website.